The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral hernia.
It was reported that after the implant, the patient experienced large amount of bowel within the subcutaneous tissue dehisced around the edges, multiple dilated proximal small loops of bowel, adhesions, abscess, necrotic fascia, abdominal compartment syndrome and ileus, fistula, succus drainage, fistula occlusion, seroma, fever, abdominal pain, fascial dehiscence, serous fluid from wound, edematous bowel, small bowel obstruction, acute gangrenous cholecystitis, central line sepsis, and open abdominal granulation wound.
Post-operative patient treatment included mesh removal surgery of previously placed permacol patch, abdominal vac placed, enteric contents were milked back into the stomach and aspirated through the ng tube, wound vac, lysis of adhesions, debriding of necrotic fascia, sump drain for small bowel fistula, split thickness skin grafts harvested from the left leg using a dermatome and applied to entire abdominal wall, removal of wound vac, tube enterostomy, hernia repair with mesh, abdominal washout, hospitalization, icu, peritoneal lavage, drainage of enterocutaneous fistula, cholecystotomy tube, closure of small bowel fistula, small bowel resection, small bowel side-to-side bppvass [sic] of the site of small bowel obstruction, gastrostomy tube, repair of massive incision with alloderm, and skin/subcutaneous flaps with skin/subcutaneous tissue relaxing, and revision surgery.
|